Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Consumer prices
Arm Holdings PLC
Alphabet Inc
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Breaking News: Investing
Novo Nordisk A/S
Investment strategy
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Novo Nordisk A/S
Sanofi SA
Breaking news
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Obesity
Drug trials
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
Companies
Pharmaceuticals
Health care industry
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
NVO
Benzinga
Markets
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
Walmart Inc
stocks
Abbott Laboratories
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Baxter International Inc
Finance
Markets
From
CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
Tags
Finance
Timken Co
Stock markets
From
CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
October 11, 2023
Tags
LVMH Moet Hennessy Louis Vuitton SE
Novo Nordisk A/S
Earnings
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Stock markets
Pfizer Inc
Diabetes
From
CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
October 10, 2023
Tags
Walmart Inc
Harley/Davidson Inc
Corning Inc
From
CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
October 05, 2023
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
Tags
Elanco Animal Health Inc
Piper Jaffray Companies
SoFi Technologies Inc
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Novartis AG
Johnson & Johnson
Companies
From
CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
October 01, 2023
Tags
CVS Health Corp
Retail
Business News
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Health & Science
Eli Lilly and Co
Business
From
CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
September 29, 2023
Tags
Breaking news
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Business
Eli Lilly and Co
Health & Science
From
CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
September 19, 2023
Tags
US: News
Biotechnology
Business News
From
CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
September 11, 2023
Tags
Investment strategy
Mondelez International Inc
CNBC Investing Club: Newsletter
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
Novo Nordisk A/S
CNBC Global CFO Council
Biotech and Pharmaceuticals
From
CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
September 07, 2023
Tags
Life Sciences
Health & Science
Eli Lilly and Co
From
CNBC.com News
Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more
September 06, 2023
Tags
Dominion Energy Inc
Economy
stocks
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug launches in the UK
September 04, 2023
Tags
Novo Nordisk A/S
Biotechnology
Europe Markets
From
CNBC.com News
Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
September 01, 2023
Tags
Pharmaceuticals
Europe News
Business
From
CNBC.com News
5 things to know before the stock market opens Friday
September 01, 2023
Tags
Business
Labor economy
Economic events
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Health care industry
Companies
Pharmaceuticals
From
CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
August 25, 2023
Tags
US: News
Business News
Biotechnology
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.